The insulin treatment of diabetes patient of our country is started late

The insulin treatment of diabetes patient of our country is started late
The insulin treatment of diabetes patient of our country is started late
It is reported ' Reporter Wang XueFei) Diabetic clinical research of largest scale in the world that was held in Beijing a few days ago - -IMPROVE studies China and fruits at the news conference, IMPROVE studies global expert panel member, Chinese Medical Association's diabetic credit and knows to General Board Professor Yang WenYing and says, as a whole, Chinese diabetic's blood glucose controls difference, the insulin treatment is started late, need further strengthening training, propaganda and education, in order to reduce a doctor and patient " resists " of insulin progressively ,Improve the therapeutic effect. It is reported, mix insulinogenic analog promise and sharp 30 and can control saccharified hemoglobin effectively in advance; Participate in the patient that study in various countries, the therapeutic effect of the Chinese patient is better. According to the introduction of gentle Great Britain Professor Yang, IMPROVE was studied and started in 2006, it was a opening, non- random clinical observation that studied. Over 20,000 patients participate in China, the proportion is largest among the patient who various countries participate in. Yang WenYing reminded, 40.5% presented the blood capillary complication before bringing into more than 20,000 Chinese patients treating and treating, 24% have trunk complication, 19% patient employ insulin treat already only.


|